Longitudinal evaluation of motor outcome measures in adults and children with FKRP mutations

Takeaway

  • Measuring standard motor outcomes can detect change over time in patients with FKRP mutations, and age and genotype should be considered in design of future clinical trials.

Why this matters

    Understanding the natural history of motor function as it relates to FKRP mutations will aid in the design of future clinical trials.